Ronald G. Collman

Dr. Ronald G. Collman, MD, is a distinguished figure in the field of HIV/AIDS research, currently serving as the Director of the Penn Center for AIDS Research (CFAR) since 2015. His leadership journey at CFAR began in 2008 when he took on the role of co-director, a position he held until his promotion to director. Dr. Collman's association with the CFAR's Virus/Molecular Core dates back to 1998, where he has been instrumental in advancing research initiatives. Joining the faculty of the Medicine University of Pennsylvania in 1990, Dr. Collman has made significant strides in academia, culminating in his appointment as Professor of Medicine and Medicine in Microbiology in 2004. His research expertise is vast, encompassing critical areas such as viral tropism, macrophage infection, and viral entry. He is also deeply involved in exploring HIV/AIDS pulmonary complications and pathogenesis, as well as neuroAIDS pathogenesis and microbiome studies. Dr. Collman's research endeavors have been consistently supported by the National Institutes of Health (NIH) since 1989, underscoring his commitment and contribution to the field. His scholarly work is further recognized through his roles on the Editorial Boards of the Journal of Clinical Investigation and the Journal of Virology, where he contributes to shaping the discourse in virology and clinical research. In addition to his research and academic responsibilities, Dr. Collman is a dedicated clinician. He serves as a clinical attending at the Hospital of the University of Pennsylvania, where he practices Critical Care Medicine in the Medical Intensive Care Unit. His dual role as a researcher and clinician allows him to bridge the gap between laboratory findings and patient care, enhancing the impact of his work on public health. Dr. Collman's career is marked by a profound dedication to understanding and combating HIV/AIDS. His contributions have not only advanced scientific knowledge but have also paved the way for improved clinical practices and patient outcomes. His ongoing research continues to push the boundaries of what is known about HIV/AIDS, with the aim of developing innovative strategies to tackle this global health challenge.